Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL814820 | 0.88 | PDPK1 (0.33) | HTR2AHTR2CHTR2B | |
| SCHEMBL4812053 | 0.85 | CHRNB2 (0.30) | CHRNB2CHRNA4IDO1HTR2AHTR2C | |
| SCHEMBL1451835 | 0.80 | CHRNB2 (0.55) | CHRNB2CHRNA4IDO1 | |
| SCHEMBL1451058 | 0.79 | PGR (0.36) | CHRNB2CHRNA4IDO1 | |
| SCHEMBL1451592 | 0.79 | IDO1 (0.40) | CHRNB2CHRNA4IDO1 | |
| SCHEMBL1450520 | 0.75 | ESR1 (0.35) | — | |
| SCHEMBL15147106 | 0.74 | IDO1 (0.53) | IDO1HTR2AHTR2CHTR2B | |
| SCHEMBL29977975 | 0.74 | IDO1 (0.53) | IDO1HTR2AHTR2CHTR2B | |
| SCHEMBL321745 | 0.74 | IDO1 (0.53) | IDO1HTR2AHTR2CHTR2B | |
| SCHEMBL5688182 | 0.72 | HTR2A (0.32) | HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060122064-A1 | Amides and method for plant diseases control with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1640360-A1 | AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122064-A1 | Amides and method for plant diseases control with the same | ARG1, ARGLU1, ARG2 | CHRNB2 3031/4885CHRNA4 2868/4885IDO1 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.